Combatting misconceptions in glaucoma testing

News
Video

Robert L. Stamper, MD, weighs in on what he think more optometrists should know about glaucoma and current misconceptions concerning glaucoma testing.

Robert L. Stamper, OD, addressed optometrists about the nuances of glaucoma testing during the recent Glaucoma 3260 meeting.

Video Transcript:

Editor's note: The below transcript has been lightly edited for clarity.

What do you wish more optometrists knew about glaucoma?

Robert L. Stamper, MD: I'd say the variability in presentation, the racial differences in susceptibility to glaucoma, and I would say the fact that glaucoma, by and large, is a slowly progressive disease, and we don't always have to make decisions in the moment, that we can wait and see how it evolves, to see if it's progressing before we initiate or escalatetreatment.

What are the most common misconceptions of glaucoma testing?

Stamper: The most common misconceptions are the infallibility of our diagnostic equipment, which kind of relates back to not having to make a momentary decision, except in extreme, extreme situations. But for the most part, with chronic glaucoma, often our machines aren't programmed to take into account ethnic and racial differences. They're based, often, on a small number of patients to develop a normative database, so what the machine prints out as being "abnormal" may not, in fact, be "abnormal," may just be a product of some genetic difference between 1 person and another. I think one should, again, except in far advanced situations, one has the ability to repeat the examination, make sure that you're where you're comfortable with the results of testing.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.
Paul Karpecki, OD, FAAO
Melissa Barnett, OD, FAAO, FSLS, FBCLA, gave 2 presentations alongside other ODs and MDs at CRU 2025.
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
© 2025 MJH Life Sciences

All rights reserved.